To determine the effect of MAP2K3 on ESCC function in vivo, we established a stable MAP2K3‐knockout (KO) cell line by using CRISPR/Cas9 in KYSE520 cells. The gene discussed is MAP2K3; the disease is esophageal squamous cell carcinoma.